Utility of FDG PET-CT Scan in Determining Pathological Response to Neo-adjuvant Chemo-radiation Therapy in Non-small Cell Lung Cancer (NSCLC)

Authors

Eliot L. Friedman MD, Lehigh Valley Health NetworkFollow
Michael F. Szwerc MD, Lehigh Valley Health NetworkFollow
Robert Kruklitis MD, Lehigh Valley Health NetworkFollow
Michael J. Weiss MPH, Lehigh Valley Health NetworkFollow
Robert Rienzo MD, Lehigh Valley Health NetworkFollow
Wen Young MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

2012

Comments

Copyright © Lehigh Valley Health Network

Published In/Presented At

Friedman, E., Szwerc, M., Kruklitis, R., Weiss, M., Rienzo, R., & Young, W. (2012). Utility of FDG PET-CT scan in determining pathological response to neo-adjuvant chemo-radiation therapy in non-small cell lung cancer (NSCLC). Poster presented at: The 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology, Chicago, IL.

Disciplines

Analytical, Diagnostic and Therapeutic Techniques and Equipment | Hematology | Medical Pathology | Medical Sciences | Medical Specialties | Medicine and Health Sciences | Oncology | Therapeutics

Department(s)

Department of Medicine, Hematology-Medical Oncology Division, Department of Medicine Faculty, Department of Surgery, Network Office of Research and Innovation

Document Type

Poster